Last updated on 11 Jan 2021
Owner Info
Intercept Pharmaceuticals, Inc. a Delaware corporation
10 Hudson Yards, 37th Floor
New York, New York, 10001 UNITED STATES OF AMERICA,
Serial Number
2126259 filed on 7 Oct 2020
Correspondent
Allens Patent & Trade Mark Attorneys
101 Collins St,
MELBOURNE, VIC, 3001 AUSTRALIA,
2126259
7 Oct 2020
7 Oct 2030
WORD
20 Apr 2020
US
Status Date | Action Taken |
---|---|
11th Jan 2021 | IP Right Registered correspondence sent |
11th Jan 2021 | IP Right Registration Published |
11th Jan 2021 | Status change to Registered/Protected |
5th Nov 2020 | Application Accepted correspondence sent |
4th Nov 2020 | IP Right has been Examined |
4th Nov 2020 | IP Right Acceptance Published |
4th Nov 2020 | Status change to Accepted |
13th Oct 2020 | Awaiting examination |
13th Oct 2020 | Examination expedited |
8th Oct 2020 | IP Right Filed correspondence sent |